Torpharm generic Cardizem CD approved
Apotex subsidiary Torpharm's diltiazem extended-release capsules approved May 20 in 120 mg, 180 mg, 240 mg, and 300 mg strengths. Reference listed drug is Biovail's Cardizem CD (1"The Pink Sheet" May 24, 2004, p. 38)...
You may also be interested in...
FDA's ANDA Approvals
The Trump administration says a COVID-19 vaccine could be available in as little as 12 months, but most experts think that is overpromising unless safety or efficacy standards are sacrificed. Many are urging pivotal studies that look at clinical outcomes, not surrogates, for US FDA approval.
When asked about an inspector general report that found hospitals are struggling with tests and resources, and are looking to the federal government to help facilitate more efficient distribution of medical devices to fight the COVID-19 crisis, President Trump attacked the report as a political hit from an Obama holdover.